Promaxo Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 29
Employees
  • Latest Deal Type
  • Series B2
  • Latest Deal Amount
  • $4.18M
Latest Deal Amount
  • Investors
  • 12

Promaxo General Information

Description

Developer of a portable MRI system designed to diagnose prostate cancer disease. The company's system consists of a magnet cart housing the magnet, gradient coils, and radiofrequency coil using prostate-specific antigen with multi-parametric MRI and fusion with a limited footprint and fringe field, enabling doctors to monitor and scan through MR imager for efficient treatment.

Contact Information

Website
www.promaxo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Other Devices and Supplies
Primary Office
  • 70 Washington Street
  • Suite 407
  • Oakland, CA 94607
  • United States
+1 (510) 000-0000

Promaxo Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Promaxo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series B2) 07-Jan-2021 $4.18M 000.00 00000 Completed Generating Revenue
6. Early Stage VC (Series B1) 21-May-2020 0000 000.00 0000 Completed Generating Revenue
5. Debt - PPP 01-May-2020 000.00 Completed Generating Revenue
4. Early Stage VC 08-Aug-2019 000 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 16-Apr-2018 00.00 00.00 000.00 Completed Generating Revenue
2. Seed Round 13-Dec-2016 $1.4M $1.4M Completed Startup
1. Grant $9M Completed Startup
To view Promaxo’s complete valuation and funding history, request access »

Promaxo Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2 000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
Series B1 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A 3,657,139 $0.000010 $0.13 $1.68 $1.68 1x $1.68 17.91%
To view Promaxo’s complete cap table history, request access »

Promaxo Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a portable MRI system designed to diagnose prostate cancer disease. The company's system consists of a magn
Diagnostic Equipment
Oakland, CA
29 As of 2021
000.00
0000 0000-00-00
00000000000 000.00

00000 00

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000000000 000000000
Markham, Canada
00 As of 0000
000.00
0000000000 0 000.00

00000000

. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla paria
0000000000 000000000
Guilford, CT
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Promaxo Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exact Imaging Venture Capital-Backed Markham, Canada 00 000.00 0000000000 0 000.00
000000000 (0000000 Venture Capital-Backed Guilford, CT 00 00000 00000000000 00000
000 000000 00000 Private Equity-Backed Genova, Italy 0000 000000000000
000000 0000000 Corporation Tokyo, Japan
0000000 Formerly VC-backed Oakwood, OH 000 00000 00000000000 00000
You’re viewing 5 of 7 competitors. Get the full list »

Promaxo Executive Team (8)

Name Title Board Seat Contact Info
Amit Vohra Ph.D Co-Founder, Chief Executive Officer, President and Chairman of Board
Dinesh Kumar Ph.D Chief Operations Officer
Aleksandar Nacev Ph.D Chief Technology Officer
Michael Bartholomew Co-Founder, Board Member, Chief Commercial Officer & Executive Vice President
David Paribello Product Manager
You’re viewing 5 of 8 executive team members. Get the full list »

Promaxo Board Members (6)

Name Representing Role Since
Abe Maingi Promaxo Board Observer 000 0000
Amit Vohra Ph.D Promaxo Co-Founder, Chief Executive Officer, President and Chairman of Board 000 0000
Dan McCormick Promaxo Board Member 000 0000
Dushyant Chipalkatty Promaxo Board Member 000 0000
Jonathan Chen Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Promaxo Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Promaxo Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Huami Corporation Minority 000 0000 000000 0
Aljit Joy Angel (individual) Minority 000 0000 000000 0
Kineticos Life Sciences Venture Capital Minority 000 0000 000000 0
Robert Hess Angel (individual) Minority 000 0000 000000 0
Almond Tree Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »